SCHEMBL3476311

SCHEMBL3476311

CCCC(N1CCC(O)(c2ccc(Cl)cc2)CC1)n1c(Nc2ccc(C)c(CC)c2)cc(=O)[nH]c1=O

nearest known ligand 0.54

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ CCR1 P32246 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3476312 0.79 — —
SCHEMBL3476316 0.70 — —
SCHEMBL3471363 0.69 — —
SCHEMBL7698417 0.66 UNG (0.52) —
SCHEMBL6773757 0.66 UNG (0.47) —
SCHEMBL6773753 0.64 — —
SCHEMBL5962422 0.58 OPRM1 (0.63) CCR1
SCHEMBL6783250 0.58 TP53 (0.73) —
SCHEMBL10287607 0.57 OPRM1 (0.63) CCR1
SCHEMBL6773760 0.56 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010134939-A2 MAMMALIAN GENES INVOLVED IN INFECTION Zirus, Inc. (US) 2010-11-25 — — WO disclosed
WO-2003011297-A1 N3-SUBSTITUTED 6-ANILINOPYRIMIDINES AND METHODS TO TREAT GRAM-POSITIVE BACTERIAL AND MYCOPLASMAL INFECTIONS UNIVERSITY OF MASSACHUSETTS (US) 2003-02-13 — — WO disclosed
Send feedback